Brazil regulator sets requirements for approval of COVID-19 vaccines

Brazil's health regulator Anvisa in a statement on Wednesday set the requirements for approving COVID-19 vaccines for emergency use in the country.

Anvisa said vaccine authorizations would be analyzed case-by-case and producers should still seek usual registration for the vaccines. To gain emergency approval, all vaccines must be in phase 3 of trials, Anvisa said.